Pharmacy and Therapeutics Committees: Leadership Opportunities in Medication Safety for Medical Toxicologists
Open Access
- 26 March 2011
- journal article
- Published by Springer Nature in Journal of Medical Toxicology
- Vol. 7 (2) , 99-102
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Conflicts of Interest on Pharmacy and Therapeutics Committees at Academic Medical CentersJournal of Medical Toxicology, 2011
- How Many “Me-Too” Drugs Is Too Many?JAMA, 2011
- Off-label prescribing of drugs for children.Current Drug Safety, 2011
- Failure to discount for conflict of interest when evaluating medical literature: a randomised trial of physiciansJournal of Medical Ethics, 2010
- President Obama's health care reform policies: Issues of interest to P&T committees.2009
- Risk Evaluation and Mitigation Strategies for Drugs with Abuse LiabilityAnnals of the New York Academy of Sciences, 2008
- ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary SystemAmerican Journal of Health-System Pharmacy, 2008
- Everyone's a Little Bit Biased (Even Physicians)JAMA, 2008
- Peer-Reviewed Publication of Clinical Trials Completed for Pediatric ExclusivityJAMA, 2006
- Financial Conflict of Interest Disclosure and Voting Patterns at Food and Drug Administration Drug Advisory Committee MeetingsJAMA, 2006